Home/Filings/8-K/0001193125-26-009895
8-K//Current report

ZIMMER BIOMET HOLDINGS, INC. 8-K

Accession 0001193125-26-009895

$ZBHCIK 0001136869operating

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 9:00 AM ET

Size

187.1 KB

Accession

0001193125-26-009895

Research Summary

AI-generated summary of this filing

Updated

Zimmer Biomet Holdings, Inc. Executive Resignation — Mark Bezjak

What Happened
Zimmer Biomet Holdings, Inc. filed a Form 8‑K reporting that on January 8, 2026 Mark Bezjak informed the company he will resign his employment (including all officer positions with the company and its affiliates) effective January 16, 2026 to pursue another business opportunity. The filing notes Mr. Bezjak was a named executive officer in the company’s 2025 proxy statement and that he ceased to be an executive officer of the company on July 1, 2025.

Key Details

  • Company: Zimmer Biomet Holdings, Inc.; filing: Form 8‑K dated January 12, 2026.
  • Resigning executive: Mark Bezjak.
  • Resignation notice given: January 8, 2026; effective date: January 16, 2026.
  • Mr. Bezjak was listed as a named executive officer in the 2025 proxy and had ceased being an executive officer on July 1, 2025.

Why It Matters
This 8‑K formally notifies investors of a management departure. Because the filing indicates Mr. Bezjak stopped serving as an executive officer on July 1, 2025, the practical impact on day‑to‑day leadership may be limited. Investors should note the change and watch for any future disclosures about succession, organizational updates, or related arrangements that could affect governance or compensation.